Background. In palliative patients, pain is the leading symptom, and pain control is one of the most important tasks of high-quality palliative care. Opioids remain the gold standard for pain relief in palliative patients, and the subcutaneous method of application has been shown to be safe, flexible, and practical. As the disease progresses, there is often an intensification of pain that becomes increasingly difficult to control. Given the limitations of oral and transdermal application of opioids, via a subcutaneous morphine pump is an alternative. Aim. The aim of this research is to demonstrate that the use of morphine via a morphine pump in palliative patients results in significantly better pain control and a higher quality of life Methods. The study will be conducted on the premises of the Pain Management Outpatient Clinic and the Palliative Care Outpatient Clinic of the Department of Anesthesiology, Critical Care and Pain Management at KBC Sisters of Mercy. Data collection will be conducted by the researcher in person over a 6-month period. The validated questionnaires NRS and ESAS will be used to assess pain, and the questionnaire EORTC QLO-C30 will be used to assess quality of life, with the consent of the author of the questionnaire. Data will be analyzed on three occasions, before the use of the morphine pump, after one week and after three weeks of use, measuring pain intensity using the NRS scale, while the ESAS questionnaire and the EORTC QLO -C30 questionnaire will be analyzed before and after three weeks. The results. From the minimum and maximum results achieved, it can be seen that after the application of the morphine pump, in the 1st and 2nd measurements, not a single patient stated a NRS value higher than 5, while the initial values went up to NRS 10. The ESAS questionnaire determined in the last measure, which is after three weeks from the beginning, that not a single patient mentions the maximum value of symptoms and difficulties. The EORTC QLQ-C30 questionnaire tested after subcutaneous administration of opioids gives results in the 2nd measurement up to a maximum value of 6 (out of a possible 7, with higher scores indicating a better condition and quality of life). Conclusion. According to the conducted research, palliative patients who are prescribed morphine pump therapy have better pain control compared to before and a better quality of life. An individual approach to palliative patients, as well as adequate titration of opioids, subcutaneously, reduces accompanying symptoms of the underlying disease, increases the ability to function on a daily basis, and ultimately improves the general quality of life.